» Articles » PMID: 10982829

The Coiled-coil Domain of Stat3 is Essential for Its SH2 Domain-mediated Receptor Binding and Subsequent Activation Induced by Epidermal Growth Factor and Interleukin-6

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2000 Sep 13
PMID 10982829
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

STAT proteins are a family of latent transcription factors that mediate the response to various cytokines and growth factors. Upon stimulation by cytokines, STAT proteins are recruited to the receptors via their SH2 domains, phosphorylated on a specific tyrosine, dimerized, and translocated into the nucleus, where they bind specific DNA sequences and activate the target gene transcription. STATs share highly conserved structures, including an N-domain, a coiled-coil domain, a DNA-binding domain, a linker domain, and an SH2 domain. To investigate the role of the coiled-coil domain, we performed a systematic deletion analysis of the N-domain and each of the alpha-helices and mutagenesis of conserved residues in the coiled-coil region of Stat3. Our results indicate that the coiled-coil domain is essential for Stat3 recruitment to the receptor and the subsequent tyrosine phosphorylation and tyrosine phosphorylation-dependent activities, such as dimer formation, nuclear translocation, and DNA binding, stimulated by epidermal growth factor (EGF) or interleukin-6 (IL-6). Single mutation of Asp170 or, to a lesser extent, Lys177 in alpha-helix 1 diminishes both receptor binding and tyrosine phosphorylation. Furthermore, the Asp170 mutant retains its ability to bind to DNA when phosphorylated on Tyr705 by Src kinase in vitro, implying a functional SH2 domain. Finally, we demonstrate a direct binding of Stat3 to the receptor. Taken together, our data reveal a novel role for the coiled-coil domain that regulates the early events in Stat3 activation and function.

Citing Articles

Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology.

Kumar S, Kumar B, Nayak R, Pandey S, Kumar N, Pai K Mol Divers. 2025; .

PMID: 39786519 DOI: 10.1007/s11030-024-11075-5.


Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma.

Kumar S, Arwind D, B H, Pandey S, Nayak R, Vithalkar M Transl Oncol. 2024; 46:102023.

PMID: 38852276 PMC: 11220551. DOI: 10.1016/j.tranon.2024.102023.


Role of STAT3 in pancreatic cancer.

Hamel Z, Sanchez S, Standing D, Anant S Explor Target Antitumor Ther. 2024; 5(5):20-34.

PMID: 38464736 PMC: 10918236. DOI: 10.37349/etat.2024.00202.


Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.

Adesoye T, Tripathy D, Hunt K, Keyomarsi K Cancers (Basel). 2024; 16(3).

PMID: 38339245 PMC: 10854592. DOI: 10.3390/cancers16030492.


Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression.

Fornari Laurindo L, Dias J, Cressoni Araujo A, Pomini K, Machado Galhardi C, Rucco Penteado Detregiachi C Front Immunol. 2024; 14:1305933.

PMID: 38259497 PMC: 10800801. DOI: 10.3389/fimmu.2023.1305933.


References
1.
Yu C, Meyer D, Campbell G, Larner A, Schwartz J, Jove R . Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science. 1995; 269(5220):81-3. DOI: 10.1126/science.7541555. View

2.
Lutticken C, Wegenka U, Yuan J, Buschmann J, Schindler C, Ziemiecki A . Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 1994; 263(5143):89-92. DOI: 10.1126/science.8272872. View

3.
Wen Z, Zhong Z, Darnell Jr J . Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995; 82(2):241-50. DOI: 10.1016/0092-8674(95)90311-9. View

4.
Quelle F, Thierfelder W, Witthuhn B, Tang B, Cohen S, Ihle J . Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J Biol Chem. 1995; 270(35):20775-80. DOI: 10.1074/jbc.270.35.20775. View

5.
Schindler C, Darnell Jr J . Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995; 64:621-51. DOI: 10.1146/annurev.bi.64.070195.003201. View